Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 17.18B P/E 65.36 EPS this Y -11.50% Ern Qtrly Grth 86.40%
Income 266.76M Forward P/E 60.77 EPS next Y 59.50% 50D Avg Chg 8.00%
Sales 1.07B PEG 5.28 EPS past 5Y 11.86% 200D Avg Chg 31.00%
Dividend N/A Price/Book 11.18 EPS next 5Y 18.35% 52W High Chg -
Recommedations 2.80 Quick Ratio 6.82 Shares Outstanding 45.09M 52W Low Chg 73.00%
Insider Own 2.02% ROA 9.55% Shares Float 44.37M Beta 1.40
Inst Own 97.09% ROE 18.24% Shares Shorted/Prior 753.62K/2.08M Price 381.02
Gross Margin 81.33% Profit Margin 24.84% Avg. Volume 1,703,123 Target Price 363.00
Oper. Margin 22.96% Earnings Date Feb 1 Volume 15,702,662 Change 0.00%
About ABIOMED, Inc.

Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5.0, Impella LD, and Impella 5.5, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; Impella Connect, a cloud-based technology that enables secure and remote viewing of the automated impella controller for physicians and hospital staffs; and OXY-1 System, a portable external respiratory assistance device. In addition, the company is developing Impella ECP, a pump for blood flow of greater than three liters per minute; Impella XR Sheath, a sheath that expands and recoils allowing small bore access and closure with Impella heart pumps; Impella BTR, a percutaneous micro heart pump with integrated motors and sensors; and preCARDIA, a catheter-mounted superior vena cava therapy system designed to rapidly treat acutely decompensated heart failure. Abiomed, Inc. sells its products through direct sales and clinical support personnel in the Germany, France, United States, Japan, Europe, Canada, Latin America, the Asia-Pacific, and the Middle East. The company was founded in 1981 and is headquartered in Danvers, Massachusetts. As of December 22, 2022, Abiomed, Inc. operates as a subsidiary of Johnson & Johnson.

ABMD Chatroom

User Image Brent24 Posted - 1 week ago

@TJmaximus it’s worth way more than $ABMD. $ABMD barely grew for years. $SWAV just getting started and already has a 2nd company they’ve bought to launch into new indications entirely.

User Image Brent24 Posted - 1 week ago

@TJmaximus It’s worth $500. The market just doesn’t understand yet. Any competition will be so far behind/inferior that it won’t gain traction. The next $ABMD

User Image Pg69 Posted - 2 months ago

$ABMD pharmaceutical sonoma An acquired report estimates the new pulse treatment at 290 dollars with a projection of nearly 100,000 patients in the US and it means quadrupling turnover in 2024 great news boommm

User Image muldoon92 Posted - 2 months ago

$SWAV feels like they’re on the M&A docket, but I’ve definitely felt this way for a long time and still no dice… $ABMD was bought at 16x revenue multiple. Impella offered more of a moat than what $SWAV has as we know others in the space are working on competing technologies. That being said, speak to any cards/vascular doc and they’ll tell you the same thing, SWAV isn’t going anywhere and will be here to stay… What type of a multiple can it command in this environment, and will it be something management accepts? Think a 250-300 offer plays out any diff this go around? $BSX $EW $MDT

User Image ManagerofRisk Posted - 2 months ago

$ABMD Did this get bought out?

User Image Torres87 Posted - 4 months ago

@RenHenInvestments JNJ dont have the money anymore after premium buyout of $ABMD

User Image sophia1987 Posted - 6 months ago

@med_bull @healthcareguru you can't compare to $ABMD because $ABMD had bigger TAM. Multiple devices, had already big international sales, more breakthrough devices in pipeline (impella ECP, STEMI DTU trial) and rates were lower at acquisition, competitors were years away, no patent problems and so on. I think they want to stay independent. Who has a money for +15B acquisition?

User Image sophia1987 Posted - 6 months ago

@TJmaximus $ABMD was trading at PE of 60 at that time, no debts (1b cash) and growth was 20%. Buyout was at PE 100... Hard to say as long there is no competition and medical people love there devices then growth will be in 20-30% in 3-4 years.

User Image Quantisnow Posted - 7 months ago

$ABMD $STIM 📰 Dr. Mehdi H. Shishehbor Appointed Chief Medical Officer of Inquis Medical https://quantisnow.com/i/4744973?utm_source=stocktwits 45 seconds delayed.

User Image Ypestis Posted - 8 months ago

$ABMD Class 1 Recall…no bueno.

User Image risenhoover Posted - 10 months ago

$ABMD ABMD / ABIOMED, Inc. Price Target Updated https://fintel.io/sfo/us/abmd?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 11 months ago

$ABMD ABMD / ABIOMED, Inc. Price Target Updated https://fintel.io/sfo/us/abmd?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 11 months ago

$ABMD ABMD / ABIOMED, Inc. Price Target Updated https://fintel.io/sfo/us/abmd?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 11 months ago

$ABMD ABMD / ABIOMED, Inc. Price Target Updated https://fintel.io/sfo/us/abmd?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 11 months ago

$ABMD ABMD / ABIOMED, Inc. Price Target Updated https://fintel.io/sfo/us/abmd?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 11 months ago

$ABMD ABMD / ABIOMED, Inc. Price Target Updated https://fintel.io/sfo/us/abmd?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 11 months ago

$ABMD ABMD / ABIOMED, Inc. Price Target Updated https://fintel.io/sfo/us/abmd?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 11 months ago

$ABMD ABMD / ABIOMED, Inc. Price Target Updated https://fintel.io/sfo/us/abmd?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 11 months ago

$ABMD ABMD / ABIOMED, Inc. Price Target Updated https://fintel.io/sfo/us/abmd?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 11 months ago

$ABMD ABMD / ABIOMED, Inc. Price Target Updated https://fintel.io/sfo/us/abmd?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 11 months ago

$ABMD ABMD / ABIOMED, Inc. Price Target Updated https://fintel.io/sfo/us/abmd

User Image Newsfilter Posted - 11 months ago

$ABMD IMPACT EU Post-Market Clinical Follow-Up Study - NCT05756751 https://newsfilter.io/a/bc0625136b4ecde4c562a4c2d75269ef

User Image MarketBeat Posted - 1 year ago

Abiomed initiated by StockNews.com at hold. www.marketbeat.com/stocks/NASDAQ/ABMD/price-target/ $ABMD

User Image macroaxis Posted - 01/28/23

$ABMD - Implied volatility is down to 2.8 for… https://www.macroaxis.com/stock-options/ABMD/ABIOMED,?utm_source=dlvr.it&utm_medium=stocktwits

User Image MarketBeat Posted - 01/27/23

Abiomed initiated by StockNews.com at hold. www.marketbeat.com/stocks/NASDAQ/ABMD/price-target/ $ABMD

User Image MarketBeat Posted - 1 year ago

Abiomed initiated by StockNews.com at hold. www.marketbeat.com/stocks/NASDAQ/ABMD/price-target/ $ABMD

User Image tickeron Posted - 1 year ago

Which stock is the best to invest? Compare $ABMD vs. $PINS. #ABIOMED https://srnk.us/go/4323145

User Image STCKPRO Posted - 1 year ago

$ABMD NEW ARTICLE : Intuitive Surgical: Valuation Hanging On By The $4 Billion Cash Thread https://www.stck.pro/news/ABMD/40748368

User Image Finscreener Posted - 1 year ago

S&P 500 $SPY Overbought stocks based on RSI indicator $DOW $OGN $MKTX $ABMD Learn more: www.finscreener.org/screener/overbought-stocks/sp500

User Image Finscreener Posted - 1 year ago

S&P 500 $SPY Overbought stocks based on RSI indicator $DOW $OGN $MKTX $ABMD Learn more: finscreener.org/screener/overbought-stocks/sp500

Analyst Ratings
Morgan Stanley Equal-Weight Nov 2, 22
Deutsche Bank Hold Nov 2, 22
William Blair Market Perform Nov 1, 22
Piper Sandler Neutral Nov 1, 22
Mizuho Buy Oct 13, 22
Piper Sandler Overweight Oct 10, 22
Deutsche Bank Buy Jul 21, 22
Morgan Stanley Underweight Jul 19, 22
Wolfe Research Peer Perform Apr 6, 22